Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans
and accounts for one to two cases per million persons annually. The rarity of this malignancy …

Thyroid carcinomas are the most common cancer of the human endocrine system and are
typically classified as papillary, follicular, anaplastic or medullary carcinomas. Although …

Anaplastic thyroid cancer is a rare and aggressive thyroid cancer with an overall survival
measured in months. Because of this poor prognosis and often advanced age at …

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new
cancers. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they …

Simple Summary The exceedingly aggressive and rare tumor, anaplastic thyroid carcinoma,
is generally resistant to traditional antitumor therapies. In recent years, targeted therapy has …

Anaplastic thyroid carcinoma (ATC) is the rarest, but deadliest histologic type among thyroid
malignancies, with a dismal median survival of 3-9 mo. Even though ATC accounts for less …

Anaplastic thyroid cancer represents 1%–2% of thyroid cancers. For its aggressiveness, it is
considered a systemic disease at the time of diagnosis. Surgery remains the cornerstone of …

Opinion statement Anaplastic thyroid cancer (ATC) is a rare but very aggressive form of
undifferentiated thyroid cancer. Due to its rapid rate of progression and invasive nature, ATC …

Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid
cancers. Although rare, ATC accounts for the majority of deaths from thyroid carcinoma. ATC …

Globally, thyroid cancer accounts for 2% of all cancer diagnoses, and can be classified as
well-differentiated or undifferentiated. Currently, differentiated thyroid carcinomas have good …